Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.055 | 0.8 |